Ramipril Capsules/tablets Generics - Manufacturers & Suppliers
Altace(US)
| Product/Composition:- | Ramipril Capsules/Tablets |
|---|---|
| Strength:- | 1.25 mg, 2.5 mg, 5 mg, 10 mg, and 20 mg |
| Form:- | Capsules/Tablets |
| Reference Brands:- | Altace(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Ramipril is an ACE inhibitor that blocks the formation of angiotensin II, leading to vasodilation, reduced blood pressure, and decreased workload on the heart. It effectively prevents strokes, heart attacks, and heart failure progression, improving cardiovascular health, reducing symptoms, and supporting long-term management of hypertension and heart disease.
Ramipril capsules and tablets, marketed as Altace in the US and as generic Ramipril across the EU, are approved for hypertension, heart failure, and cardiovascular risk reduction. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance supports timely approval, safe use, and worldwide availability of ramipril, enabling effective blood pressure and cardiovascular management globally.